Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more?

Cell Death Dis. 2020 May 11;11(5):350. doi: 10.1038/s41419-020-2533-x.

Author

Eric C LaCasse¹

Affiliation

¹ Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, K1H 8L1, Canada. eric@arc.cheo.ca.

No abstract available

Publication types

Review

MeSH terms

Female
Humans
Inhibitor of Apoptosis Proteins / antagonists & inhibitors*
Models, Biological
Molecular Targeted Therapy
Signal Transduction
Translational Research, Biomedical
Triple Negative Breast Neoplasms / pathology*

Substances

Inhibitor of Apoptosis Proteins